SG11201909663SA - Compositions for treatment of hyperglycemia in diabetes mellitus patients - Google Patents
Compositions for treatment of hyperglycemia in diabetes mellitus patientsInfo
- Publication number
- SG11201909663SA SG11201909663SA SG11201909663SA SG11201909663SA SG 11201909663S A SG11201909663S A SG 11201909663SA SG 11201909663S A SG11201909663S A SG 11201909663SA SG 11201909663S A SG11201909663S A SG 11201909663SA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- compositions
- pct
- diabetes mellitus
- hyperglycemia
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 3
- 201000001421 hyperglycemia Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000004383 Steviol glycoside Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 229930182488 steviol glycoside Natural products 0.000 abstract 1
- 235000019411 steviol glycoside Nutrition 0.000 abstract 1
- 150000008144 steviol glycosides Chemical class 0.000 abstract 1
- 235000019202 steviosides Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762486657P | 2017-04-18 | 2017-04-18 | |
| PCT/US2018/028140 WO2018195179A1 (fr) | 2017-04-18 | 2018-04-18 | Compositions destinées au traitement de l'hyperglycémie chez des patients atteints de diabète sucré |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201909663SA true SG11201909663SA (en) | 2019-11-28 |
Family
ID=63856877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201909663S SG11201909663SA (en) | 2017-04-18 | 2018-04-18 | Compositions for treatment of hyperglycemia in diabetes mellitus patients |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200069710A1 (fr) |
| EP (1) | EP3612035A4 (fr) |
| CN (1) | CN110944521A (fr) |
| BR (1) | BR112019021858A2 (fr) |
| MX (1) | MX2019012459A (fr) |
| PH (1) | PH12019550216A1 (fr) |
| SG (1) | SG11201909663SA (fr) |
| WO (1) | WO2018195179A1 (fr) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001279593A1 (en) * | 2001-02-01 | 2002-08-12 | Soren Gregersen | A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| EP4108668A1 (fr) * | 2010-03-12 | 2022-12-28 | PureCircle USA Inc. | Glycosides de stéviol de grande pureté |
| WO2012082677A1 (fr) * | 2010-12-13 | 2012-06-21 | Cargill, Incorporated | Mélanges de glycosides |
| CN102204611A (zh) * | 2011-03-31 | 2011-10-05 | 遵义陆圣康源科技开发有限责任公司 | 含有机高浓度茶多酚液体饮品 |
| US9877501B2 (en) * | 2011-06-03 | 2018-01-30 | Purecircle Sdn Bhd | Stevia composition |
| JP2014529994A (ja) * | 2011-09-15 | 2014-11-17 | シージェイ チェイルジェダング コーポレイション | 遅消化性成分を含有する糖尿改善用甘味素材組成物 |
| CN103783615A (zh) * | 2014-02-21 | 2014-05-14 | 郝振东 | 一种降血糖的饮料及其制备方法 |
| CN104026446B (zh) * | 2014-05-15 | 2016-08-24 | 广东省农业科学院蚕业与农产品加工研究所 | 一种适合于高血糖人群服用的营养代餐粉及其制备方法 |
| CN104687176A (zh) * | 2015-02-10 | 2015-06-10 | 叶节和 | 一种植物饮料及其制备方法 |
| CN106359784A (zh) * | 2016-08-30 | 2017-02-01 | 东台纳盛特生物科技有限公司 | 一种以甜菊糖苷为甜味剂的无糖巧克力及其制备方法 |
-
2018
- 2018-04-18 US US16/605,826 patent/US20200069710A1/en not_active Abandoned
- 2018-04-18 EP EP18788501.7A patent/EP3612035A4/fr not_active Withdrawn
- 2018-04-18 WO PCT/US2018/028140 patent/WO2018195179A1/fr unknown
- 2018-04-18 SG SG11201909663S patent/SG11201909663SA/en unknown
- 2018-04-18 MX MX2019012459A patent/MX2019012459A/es unknown
- 2018-04-18 BR BR112019021858-0A patent/BR112019021858A2/pt not_active Application Discontinuation
- 2018-04-18 CN CN201880034724.4A patent/CN110944521A/zh active Pending
-
2019
- 2019-10-18 PH PH12019550216A patent/PH12019550216A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20200069710A1 (en) | 2020-03-05 |
| WO2018195179A1 (fr) | 2018-10-25 |
| MX2019012459A (es) | 2019-12-19 |
| CN110944521A (zh) | 2020-03-31 |
| EP3612035A4 (fr) | 2021-01-06 |
| EP3612035A1 (fr) | 2020-02-26 |
| BR112019021858A2 (pt) | 2020-05-26 |
| PH12019550216A1 (en) | 2020-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201906412SA (en) | Pyridine compounds as allosteric shp2 inhibitors | |
| SG11201807784SA (en) | 3-desoxy derivative and pharmaceutical compositions thereof | |
| SG11201907034PA (en) | Methods of treating influenza | |
| SG11201909963YA (en) | Methods for treating dravet syndrome | |
| SG11201903882VA (en) | Il-2 variants for the treatment of autoimmune diseases | |
| SG11201909960UA (en) | Methods for improving memory and cognition and for treating memory and cognitive disorders | |
| SG11201906431UA (en) | Method for the treatment of thromboembolism | |
| SG11201806342SA (en) | Glucagon and glp-1 co-agonists for the treatment of obesity | |
| SG11201909155VA (en) | Ask1 inhibitor compounds and uses thereof | |
| SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201908326YA (en) | Methods of treating neurodegenerative diseases | |
| SG11201907604UA (en) | Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan | |
| SG11201907583TA (en) | Methods for treating complement-mediated diseases and disorders | |
| SG11201907804QA (en) | Pharmaceutical composition comprising selexipag | |
| SG11201908325PA (en) | Process for the preparation of glucuronide drug-linkers and intermediates thereof | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201906987RA (en) | Combination of a ppar agonist with a fxr agonist | |
| SG11201809882XA (en) | Pharmaceutical combinations for treating cancer | |
| SG11202000494UA (en) | Drug delivery composition | |
| SG11201901063SA (en) | Therapeutic agents for neurodegenerative diseases | |
| SG11201804587QA (en) | Isoindole compounds | |
| SG11201901048VA (en) | Pharmaceutical compositions and uses directed to lysosomal storage disorders | |
| SG11201908513RA (en) | Peptides for treatment of diabetes |